Danielle Demmas

Danielle Demmas is an accomplished Specialty Account Manager for the Psychiatry Business Unit at Axsome Therapeutics, Inc., with experience in the sale and promotion of CNS and sleep medications. Prior roles include Specialty Sales Consultant at Jazz Pharmaceuticals, Therapeutic CNS Sales Specialist at Sunovion Pharmaceuticals, and CNS Sales Specialist at AstraZeneca. Danielle Demmas began in the pharmaceutical industry as a Professional Sales Representative for PDI, Inc / Pfizer, where responsibilities included the launch of Quillivant XR, an extended-release ADHD treatment. Additional experience includes promoting Takeda's portfolio and managing sales for Novartis and Valeant Pharmaceuticals. Danielle Demmas holds a Bachelor of Arts in Education from Texas Christian University.